Advanced Medical Solutions Group plc,the world-leading specialist in tissue-healing technologies, announces the appointment of Liz Shanahan, a current Non-Executive Director of AMS, as Chair of the Board. Liz will succeed current Chair Peter Allen on 1 January 2024, following a handover period. As previously communicated, Peter Allen is stepping down after ten years with the Group.

Liz is a life sciences entrepreneur with extensive experience advising leading global pharmaceutical and healthcare organizations on their communications. She is currently a Non-Executive Director of AIM-listed businesses Inspiration Healthcare Group plc and Celadon Pharmaceuticals plc and was previously Non-Executive Director of UDG Healthcare plc until its £2.8 billion takeover in August 2021. Between 2011 and 2014, she was Global Head of Healthcare & Lifesciences at the NYSE-listed management consultancy, FTI Consulting Inc. Liz is a Trustee of CW+, the charitable arm of Chelsea & Westminster Foundation Trust Hospital in London and a member of the organisation's Innovations Advisory Board.

Alongside her Board appointments she is a business advisor and Executive coach. Upon appointment, Liz Shanahan will replace Peter Allen as Chair of the Nomination Committee. A search is underway for the appointment of an additional independent Non-Executive Director.